Michael Goguen

Two Bear Capital thesis

Abilita Therapeutics Abilita Therapeutics enables discovery of novel therapeutics for previously undruggable membrane protein targets. Abilita Therapeutics enables discovery of novel therapeutics for previously undruggable membrane protein targets. About the company Abilita Therapeutics on LinkedIn Abilita Therapeutics website Abilita Therapeutics is a biotech company specializing in discovering and developing therapies for the most challenging membrane proteins, including GPCRs, ion channels and transporters. Despite their high significance, hundreds of such drug targets remain untapped. Abil

Sector and stage focus

• Seed: Security, BioTech, Consumer Health, AI, Cybersecurity, Health IT, Digital Health
• Series A: Consumer Health, Security, Health IT, BioTech, AI, Cybersecurity, Digital Health
• general: Los Angeles / Southern California, San Francisco Bay Area

Is Michael Goguen a fit for your round?

Upload your pitch deck and see whether Michael Goguen appears in your top 20 matches.